Device Trial Radar · NCT07842224
The Effect of Digitally Enabled District (DED 2.0) Ecosystem on the Completeness and Timeliness of Maternal and Neonatal Services in Primary Health Care
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
10,800
Planned (sponsor's estimate)
Start
Oct 22, 2026
Primary completion
May 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Summit Institute for Development, IndonesiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Bill and Melinda Gates Foundation
- First posted
- Sep 25, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Health services research
- FDA-regulated device
- No
- Who can join
- Female only
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
DED 2.0 is a stepped-wedge cluster-randomized trial testing whether an integrated digital health ecosystem (KuApps, a service-monitoring dashboard, AI-assisted OCR for handwritten records, two-way WhatsApp-based health communication, and an automated worker-support tool) improves the completeness and timeliness of maternal and neonatal primary health care services, delivered through 45 Puskesmas in Garut Regency, West Java, Indonesia.
Conditions
- Digital Health
- Maternal Health Services
- Prenatal Care
- Intensive Care, Neonatal
- Postnatal Care
Interventions
Digitally Enabled District (DED)Device
The research adopts a stepped-wedge cluster-randomized design. Puskesmas are randomized sequentially to receive the intervention. Following a one-month baseline (retrospective data of Aug-Sept, taken in October), an additional set of 15 clusters begins the intervention at the start of each three-month step: step one covers randomisation and digital-readiness training for that wave, and the remainder of the step is given over to monitoring utilisation of the digital platform. Three successive steps of three months each follow this pattern until the full sample is covered, within a 9-month rollout-and-monitoring window.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Completeness of Antenatal Care (ANC) Services within the Gestational-Age WindowTime frame: From first ANC contact up to 40 weeks gestation, assessed up to 9 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Summit Institute for Development
Mataram, West Nusa Tenggara, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.